| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |